DBV Technologies said first-quarter 2026 net loss widened to $47.6 million from $27.1 million a year earlier, as total operating expenses climbed to $48.8 million from $27.4 million.
Research and development spending rose to $33.4 million from $21.5 million, an increase of $11.9 million, while sales and marketing expenses increased to $4.8 million from $0.3 million and general and administrative expenses increased to $10.5 million from $5.6 million.
Operating loss was $47.9 million, compared with $26.6 million in the first quarter of 2025. Loss before taxes widened to $47.4 million from $27.1 million.
The company reported operating income of $0.9 million, up slightly from $0.8 million a year earlier, and financial income of $0.5 million versus a $0.5 million expense in the prior-year period.
Cash and cash equivalents were $229 million at March 31, 2026, up from $194 million at Dec. 31, 2025. DBV said net cash used in operating activities was $49 million in the quarter, compared with $20 million in the same period last year. Net cash provided by financing activities was $89 million, driven by the full exercise of warrants tied to its March 2025 private placement.
The company said its cash position is expected to fund operations into the second quarter of 2027, up from the prior quarter’s year-end cash balance of $194 million. The market has reacted to these announcements by moving the company's shares 2.38% to a price of $19.80. For the full picture, make sure to review DBV Technologies's 8-K report.
